Drug Inspector Suspended Over Negligence In Death Of Kalpana Mishra During Delivery; FIR Ordered Against Blood Centre In MP’s Rewa
Bhopal (Madhya Pradesh): The Madhya Pradesh Food and Drug Administration (FDA) has suspended Rewa district drug inspector Radheshyam Batti for alleged serious negligence, arbitrariness and indiscipline in connection with the death of Kalpana Mishra during delivery in Rewa. The suspension order was issued on Wednesday by FDA. Batti was the drug inspector responsible for the jurisdiction under…
The Madhya Pradesh Food and Drug Administration (FDA) has suspended Rewa district drug inspector Radheshyam Batti for serious negligence, arbitrariness and indiscipline following Kalpana Mishra's death during delivery in Rewa. Batti, who oversaw the jurisdiction where Atharva Blood Centre was operating, received the suspension order from the FDA on Wednesday, following instructions from the Public Health and Medical Education Department on September 15 and an ongoing inquiry by a committee led by the National Health Mission director on August 26.
During his suspension, Batti will be based at the deputy director, FDA's office in Shahdol and will receive a subsistence allowance as per the rules. On the same day, the FDA directed the chief medical and health officer, along with the ex-officio deputy director, FDA, Rewa, to file a criminal complaint against Atharva Blood Centre for alleged irregularities.
The administration has further instructed its state licensing authority and controlling authority to work with the Rewa drug inspector to ensure the department is informed of any actions taken.
Written by urgent.news from Free Press Journal's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
